Immucell Corp

ICCC Nasdaq SEC CIK 811641
Follow Immucell Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $8M +46% vs same quarter last year
Net income $952.5K +781.6% vs same quarter last year
EPS, diluted $0.10 +600% vs same quarter last year
Operating cash flow $755.9K +163.9% vs same quarter last year
Revenue by quarter
$7.8M
$8.1M
$6.4M
$5.5M
$7.6M
$10.4M
$7.2M
$8M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$10M$0$10M$20M$30MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$27.6M−$1M
FY24$26.5M−$2.2M
FY23$17.5M−$5.8M
FY22$18.6M−$2.5M
FY21$19.2M−$78.3K
FY20$15.3M−$1M
FY19$13.7M−$1.3M
FY18$11M−$2.3M
FY17$10.4M−$168.1K
FY16$9.5M$508.4K
FY15$10.2M$1.2M
FY14$7.6M−$167.2K
FY13$6M$117.4K
FY12$5.4M$89.5K
FY11$5.1M−$409.5K
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−50%−25%0%25%50%75%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2541.4%6%−3.8%
FY2430%−6.2%−8.1%
FY2322.1%−32.9%−33.1%
FY2241.2%−12.4%−13.4%
FY2145%1.3%−0.4%
FY2044.7%−9%−6.7%
FY1949.1%−7%−9.4%
FY1847.3%−13.2%−21.1%
FY1750.1%−2.3%−1.6%
FY1656.8%9.3%5.3%
FY1561.1%20.7%11.9%
FY1458.6%−2.7%−2.2%
FY1350.9%−0.3%2%
FY1256.7%4.5%1.7%
FY1155.1%−12.4%−8%
Free cash flowOperating cash flow minus capital expenditure
−$20M−$15M−$10M−$5M$0$5MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$1.2M
FY24−$107.8K
FY23−$6.6M
FY22−$5.5M
FY21−$1.7M
FY20−$2.8M
FY19−$1.2M
FY18−$2.4M
FY17−$16.6M
FY16−$3.8M
FY15$181K
FY14−$1.2M
FY13$501K
FY12$69K
FY11−$281.1K
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Immucell
  • Healthcare median
−100%−75%−50%−25%0%25%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearImmucellHealthcare median
FY25−3.8%−30.6%
FY24−8.1%−47%
FY23−33.1%−58%
FY22−13.4%−80.4%
FY21−0.4%−71.8%
FY20−6.7%−62.2%
FY19−9.4%−46.2%
FY18−21.1%−49.6%
FY17−1.6%−45.9%
FY165.3%−36%
FY1511.9%−37.8%
FY14−2.2%−35.5%
FY132%−37.1%
FY121.7%−29.1%
FY11−8%−27.9%